Company Monitoring Page for Roche

latest headlines for company on cafepharma

Roche deal fails to Repare the licensing scene
EP Vantage
Tue, 06/14/22 - 11:02 am
Tags:
Roche, Repare Therapeutics, licensing
Regeneron's Eylea could lose 30% of its patients to Roche's Vabysmo over the next year: analyst survey
Fierce Pharma
Mon, 06/13/22 - 09:46 pm
Tags:
Regeneron, Eylea, Vabysmo, Roche, wet-AMD
Roche keeps the faith in new cancer immunotherapy despite trial setbacks
BioPharma Dive
Tue, 06/7/22 - 10:30 am
Tags:
Roche, tiragolumab, lung cancer, clinical trials, ASCO 2022
ASCO: BioNTech's Roche-partnered cancer vaccine combo hints at survival benefit in prostate cancer
Fierce Biotech
Sun, 06/5/22 - 11:45 pm
Tags:
ASCO 2022, BioNTech, Roche, vaccines, cancer vaccines, pancreatic cancer
Biogen, Samsung Bioepis launch ranibizumab-nuna in US
Ophthalmology Today
Fri, 06/3/22 - 09:11 am
Tags:
Biogen, Samsung Bioepis, ranibizumab, ranibizumab-nuna, biosimilars, Roche, Lucentis, retinal disease
Roche pays Repare $125M to join Big Pharma peers in cancer race
Fierce Biotech
Thu, 06/2/22 - 10:36 am
Tags:
Roche, cancer, ovarian cancer, Repare Therapeutics
Who needs Humira? AbbVie projected to be the top pharma company by sales in 2028: analysts
Fierce Pharma
Wed, 06/1/22 - 10:15 am
Tags:
AbbVie, Roche, Pfizer, Humira
Microcap's effort to take on Eylea with Avastin biosimilar faces significant FDA roadblock
Endpoints
Tue, 05/31/22 - 10:51 am
Tags:
Outlook Therapeutics, Avastin, biosimilars, wet age-related macular degeneration, Roche, bevacizumab
Roche puts pressure on SMA rivals with new FDA approval
Pharmaforum
Tue, 05/31/22 - 10:33 am
Tags:
Roche, PTC Therapeutics, SMA, Evrysdi, FDA
Abbvie to become the biggest of pharmas in 2028
EP Vantage
Mon, 05/30/22 - 10:13 am
Tags:
AbbVie, Humira, Pfizer, Novartis, Bristol Myers Squibb, Roche
Roche trumpets new glofitamab data in lymphoma at ASCO
Pharmaforum
Fri, 05/27/22 - 10:24 am
Tags:
Roche, ASCO 2022, glofitamab, lymphoma, bispecific antibodies
3 cancer drug studies to watch at next month’s ASCO meeting
BioPharma Dive
Thu, 05/26/22 - 10:47 pm
Tags:
ASCO 2022, AstraZeneca, Enhertu, Gilead Sciences, Trodelvy, Roche, tiragolumab, cancer
Roche unveils three new monkeypox tests as cases rise
Endpoints
Wed, 05/25/22 - 11:38 pm
Tags:
Roche, diagnostics, monkeypox
Diagnostics beat implants in the race to market
EP Vantage
Tue, 05/24/22 - 10:22 am
Tags:
diagnostics, devices, Medtech, Roche, Qiagen, Asahi Kasei, Abbott Labs
Roche and bluebird bio settle year-long trademark case, but keep quiet on the details
Endpoints
Thu, 05/19/22 - 08:59 pm
Tags:
Bluebird Bio, Roche, Spark Therapeutics, trademark, legal
Big pharma’s biggest spenders revealed
EP Vantage
Tue, 05/17/22 - 10:29 am
Tags:
R&D, licensing, M&A, COVID-19, Big Pharma, Bristol Myers Squibb, JNJ, AbbVie, Sanofi, Merck, Novartis, Pfizer, AstraZeneca, Roche, GSK, Eli Lilly
EHA 2022 preview – some good news at last
EP Vantage
Mon, 05/16/22 - 10:14 am
Tags:
EHA, Caribou Biosciences, CB-010, Gracell, Autolus, Roche, Curocell, ADC Therapeutics, Mustang Bio
Checkmate details bleak future if $250M Regeneron merger does not close
Fierce Biotech
Sun, 05/15/22 - 11:17 pm
Tags:
Checkmate Pharmaceuticals, Roche, M&A
Novartis' Sandoz strikes at Roche with first US generic of blockbuster Esbriet
Fierce Pharma
Fri, 05/13/22 - 10:46 am
Tags:
Novartis, Sandoz, generics, Roche, Esbriet, idiopathic pulmonary fibrosis
Opportunities arise for once-spurned partners
EP Vantage
Fri, 05/13/22 - 10:34 am
Tags:
Pfizer, Biohaven, licensing, M&A, Aurinia, Bristol Myers Squibb, AbbVie, Alector, Arcus Biosciences, Biogen, Blueprint Medicines, CureVac, Gilead Sciences, GSK, Incyte, MorphoSys, Roche, Nestle, SAGE Therapeutics, Sarepta Therapeutics, Seres Therapeutics, Syndax

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.